Enanta Pharmaceuticals Inc. sell StockNews.com
Start price
02.09.23
/
50%
€13.00
Target price
02.09.24
-
Performance (%)
-14.62%
End price
03.09.24
€11.10
Summary
This prediction ended on 03.09.24 with a price of €11.10. The prediction for Enanta Pharmaceuticals Inc. closed with a convincing performance of -14.62%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Enanta Pharmaceuticals Inc. | -6.364% | -6.364% | 88.991% |
| iShares Core DAX® | -1.742% | -10.677% | -0.889% |
| iShares Nasdaq 100 | -2.583% | -3.319% | 11.124% |
| iShares Nikkei 225® | -1.165% | -9.362% | 23.687% |
| iShares S&P 500 | -1.422% | -3.762% | 7.187% |
Comments by StockNews_com for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ENTA provided by MarketBeat
In the thread Trading Enanta Pharmaceuticals Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€15.20
06.04.24
06.04.24
-
06.04.25
06.04.25
-72.89%
07.04.25
07.04.25
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.70
30.09.23
30.09.23
-
30.09.24
30.09.24
-10.75%
01.10.24
01.10.24